Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study
Abstract Aims Semaglutide, a GLP-1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The SEMALEAN study aims to evaluate these parameters in patients with obesity treated with Semaglutide (2.4 mg). Materials and Methods This prospective study enrolled 115 patients with […]
Fat jabs helped me lose 10.5st after I’d been obese since childhood – now I feel 21 instead of being in an early grave
A MUM who battled obesity from a young age has shared how she was eating her way toward an early grave before trying weight loss jabs. She splurged £2,000 on the medication, but it enabled her to finally shift the weight and gave her a new lease on life. Tina Bashford was already classed as […]
Carolyn Hax: Image-conscious family finds new ways to harp on weight
With GLP-1 drugs in the mix now, a 30-something letter writer is under all new pressure from weight-obsessed parents.
Carolyn Hax: Image-conscious family finds new ways to harp on weight
With GLP-1 drugs in the mix now, a 30-something letter writer is under all new pressure from weight-obsessed parents.
PepsiCo Tops Earnings Estimates on Strong Demand for Healthier Snacks
PepsiCo Inc. reported on Oct. 9 third-quarter earnings that exceeded expectations, driven by healthier snacks. The company generated $23.94 billion in revenue in the quarter, outpacing its forecasted $23.86 billion. In addition, its earnings per share (EPS) were $2.29, surpassing the forecast of $2.26. Ramon Laguarta, chairman and CEO of PepsiCo, credits many factors for […]
Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger
We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to end at $54.08 apiece following announcements that it was set to merge with Novo Nordisk in a […]
CDC’s vaccine advisers plan big changes to childhood shots
Click in for more news from The Hill {beacon} Health Care The Big Story CDC’s vaccine advisers plan big changes to childhood shots The Centers for Disease Control’s (CDC) vaccine advisory panel is planning to make some major changes to the recommended shots for kids. That could include the timing of certain vaccines and […]
GLP-1s May Throw Off Some Medical Scans
(MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. Doctors performing certain medical scans on patients taking GLP-1 receptor…
The GLP-1R Agonist Semaglutide Reduces Motivated Running and Alters Dopamine Dynamics in the Nucleus Accumbens
Glucagon-like peptide-1 receptor (GLP-1R) agonists have recently emerged as powerful tools for the treatment of obesity through their ability to suppress food intake. However, their effects on non-ingestive motivated behaviors remain incompletely understood. Here, we show that the long-acting GLP-1R agonist semaglutide (SG) suppresses voluntary wheel running in both lean and diet-induced obese mice. Importantly, […]
GLP-1 drugs could save Uncle Sam billions — Congress should account for that
Obesity is a major public health and economic challenge in the US, costing the health care system an estimated $173 billion annually, and the Congressional Budget Office should refine its scoring methods to account for the long-term economic and societal costs of obesity and the efforts to mitigate it.